Thirteen mutations in the CASQ2 gene have been identified in CPVT patients, in sudden death syndrome25,26, and three of them are non-synonymous polymorphisms (cSNP)24,27. This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.